181 related articles for article (PubMed ID: 14501706)
21. [Ultrasound-guided cryosurgery of the prostate: short- and long-term experience].
Minardi D; Polito M; Galosi AB; Yehia M; Dellabella M; Lugnani F; Muzzonigro G
Arch Ital Urol Androl; 2000 Dec; 72(4):270-5. PubMed ID: 11221053
[TBL] [Abstract][Full Text] [Related]
22. Cryosurgical ablation of the prostate: high risk patient outcomes.
Prepelica KL; Okeke Z; Murphy A; Katz AE
Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
[TBL] [Abstract][Full Text] [Related]
23. Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up.
Lee F; Bahn DK; McHugh TA; Kumar AA; Badalament RA
Anticancer Res; 1997; 17(3A):1511-5. PubMed ID: 9179188
[TBL] [Abstract][Full Text] [Related]
24. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results.
Cohen JK; Miller RJ; Rooker GM; Shuman BA
Urology; 1996 Mar; 47(3):395-401. PubMed ID: 8633408
[TBL] [Abstract][Full Text] [Related]
25. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
Kang SH; Kim JW; Bae JH; Park HS; Moon DG; Yoon DK; Cheon J; Kim JJ
Asian J Androl; 2006 Sep; 8(5):629-36. PubMed ID: 16847531
[TBL] [Abstract][Full Text] [Related]
26. Active rectal wall protection using direct transperineal cryo-needles for histologically proven prostate adenocarcinomas.
Cytron S; Paz A; Kravchick S; Shumalinski D; Moore J
Eur Urol; 2003 Sep; 44(3):315-20; discussion 320-1. PubMed ID: 12932929
[TBL] [Abstract][Full Text] [Related]
27. Prospective trial of cryosurgical ablation of the prostate: five-year results.
Donnelly BJ; Saliken JC; Ernst DS; Ali-Ridha N; Brasher PM; Robinson JW; Rewcastle JC
Urology; 2002 Oct; 60(4):645-9. PubMed ID: 12385926
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer with large glands treated with 3-dimensional computerized tomography guided pararectal brachytherapy: up to 8 years of followup.
Koutrouvelis PG; Lailas N; Katz S; Sehn J; Gil-Montero G; Khawand N
J Urol; 2003 Apr; 169(4):1331-6. PubMed ID: 12629354
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer: US-guided percutaneous cryoablation. Work in progress.
Bahn DK; Lee F; Solomon MH; Gontina H; Klionsky DL; Lee FT
Radiology; 1995 Feb; 194(2):551-6. PubMed ID: 7529937
[TBL] [Abstract][Full Text] [Related]
30. A report on major complications and biochemical recurrence after primary and salvage cryosurgery for prostate cancer in patients with prior resection for benign prostatic hyperplasia: a single-center experience.
Ullal AV; Korets R; Katz AE; Wenske S
Urology; 2013 Sep; 82(3):648-52. PubMed ID: 23831070
[TBL] [Abstract][Full Text] [Related]
31. Focal cryosurgical ablation of the prostate: a single institute's perspective.
Hale Z; Miyake M; Palacios DA; Rosser CJ
BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
[TBL] [Abstract][Full Text] [Related]
32. Cryosurgical ablation of the prostate for localized adenocarcinoma: a preliminary experience.
Wake RW; Hollabaugh RS; Bond KH
J Urol; 1996 May; 155(5):1663-6. PubMed ID: 8627849
[TBL] [Abstract][Full Text] [Related]
33. The role of cryosurgery of the prostate for nonsurgical candidates.
Al Ekish S; Nayeemuddin M; Maddox M; Pareek G
JSLS; 2013; 17(3):423-8. PubMed ID: 24018080
[TBL] [Abstract][Full Text] [Related]
34. [Cryosurgery in the management of prostate cancer].
Pontones Moreno JL; Morera Martínez JF; Vera Donoso CD; Jiménez Cruz JF
Actas Urol Esp; 2007 Mar; 31(3):211-32. PubMed ID: 17658150
[TBL] [Abstract][Full Text] [Related]
35. PSA elevation during prostate cryosurgery and subsequent decline.
Leibovici D; Zisman A; Lindner A; Stav K; Siegel YI
Urol Oncol; 2005; 23(1):8-11. PubMed ID: 15885576
[TBL] [Abstract][Full Text] [Related]
36. Prostate cryoablation: prospective analysis comparing high- and low-risk prostate cancer outcomes.
El Hayek OR; Alfer W; Reggio E; Pompeo AC; Arap S; Lucon AM; Srougi M
Urol Int; 2008; 81(2):186-90. PubMed ID: 18758217
[TBL] [Abstract][Full Text] [Related]
37. [Role of transrectal ultrasonography in the follow-up of patients treated with prostatic cryosurgery].
Galosi AB; Muzzonigro G; Polito M; Minardi D; Dellabella M; Lugnani F; Polito M
Arch Ital Urol Androl; 2000 Dec; 72(4):276-81. PubMed ID: 11221054
[TBL] [Abstract][Full Text] [Related]
38. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications.
Chin JL; Pautler SE; Mouraviev V; Touma N; Moore K; Downey DB
J Urol; 2001 Jun; 165(6 Pt 1):1937-41; discussion 1941-2. PubMed ID: 11371885
[TBL] [Abstract][Full Text] [Related]
39. The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer.
Mustafa M; Delacroix S; Ward JF; Pisters L
World J Surg Oncol; 2015 Dec; 13():340. PubMed ID: 26691335
[TBL] [Abstract][Full Text] [Related]
40. Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostate.
El-Zawahry AM; Clarke HS; Eskridge MR; Rieter W; Onicescu G; Garrett-Mayer E; Gordon LL; Keane TE
Urology; 2010 Nov; 76(5):1162-7. PubMed ID: 20434196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
